Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huynh, P. N.
Right arrow Articles by Swerdloff, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huynh, P. N.
Right arrow Articles by Swerdloff, R. S.

Journal of Andrology, Vol 21, Issue 5 689-699, Copyright © 2000 by The American Society of Andrology


JOURNAL ARTICLE

Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats

P. N. Huynh, A. P. Hikim, C. Wang, K. Stefonovic, Y. H. Lue, A. Leung, V. Atienza, S. Baravarian, V. Reutrakul and R. S. Swerdloff
Department of Medicine, Harbor-UCLA Medical Center, and Harbor-UCLA Research and Education Institute, Torrance, California 90509, USA.

Prior studies had suggested that triptolide, a diterpene triepoxide isolated from a Chinese medicinal plant, might be an attractive candidate as a post-testicular male contraceptive agent. Despite the promise that triptolide would not affect testis function, nagging concerns remained that a delayed onset of testicular effect might exist. The objectives of this study were to assess the effects of relatively longer treatment duration of triptolide on fertility, spermatogenesis, and epididymal sperm pathophysiology; and to evaluate the reversibility of these effects after the cessation of treatment. Adult male Sprague-Dawley rats were fed daily with either 30% gum acacia as a vehicle control (n = 12) or 100 microg/kg body weight (BW) of triptolide for 82 days (n = 12) followed by a recovery period of up to 14 weeks (n = 6). At the end of the treatment period, all rats treated with triptolide were sterile. Cauda epididymal sperm content decreased by 84.8% and sperm motility was reduced to zero. In addition, virtually all cauda epididymal sperm in the triptolide-treated group exhibited severe structural abnormalities. The most striking changes observed were head-tail separation, premature chromatin decondensation of sperm nuclei, a complete absence of the plasma membrane of the entire middle and principle pieces, disorganization of the mitochondrial sheath, and aggregation of many sperm tails. Longer treatment duration of triptolide also affected spermatogenesis, with marked variability in the response of individual animals. The degree of damage ranged from apparently normal-looking seminiferous tubules to flattened seminiferous epithelium lined by a single layer of cells consisting of Sertoli cells and a few spermatogonia. Affected tubules exhibited intraepithelial vacuoles of varying sizes, multinucleated giant cells, germ cell exfoliation, and tubular atrophy. Recovery occurred as early as 6 weeks after cessation of treatment. By 14 weeks, 4 out of 6 triptolide-treated males were fertile and the females that were impregnated by 3 out of 4 triptolide-treated male rats produced apparently normal litters. These results suggest that triptolide has 2 phenotypic effects on mature and maturing germ cells. The first action appears earlier and manifests mainly in epididymal sperm. The second action presumably is directly on germ cells in testis and causes a variable impairment of spermatogenesis that may not be completely reversible. It is unclear if the earlier effect is a delayed manifestation of subtle testicular injury or post-testicular action.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. T. Page, J. K. Amory, and W. J. Bremner
Advances in Male Contraception
Endocr. Rev., June 1, 2008; 29(4): 465 - 493.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Wang, S. Yang, Y. Su, Z. Xiao, C. Wang, X. Li, L. Lin, B. M. Fenton, S. F. Paoni, I. Ding, et al.
Enhanced Antitumor Effect of Combined Triptolide and Ionizing Radiation
Clin. Cancer Res., August 15, 2007; 13(16): 4891 - 4899.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
X.-y. Tang, Y.-q. Zhu, W.-h. Tao, B. Wei, and X.-l. Lin
Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma
Postgrad. Med. J., May 1, 2007; 83(979): 338 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Zhou, W. Tang, Y.-X. Ren, P.-L. He, F. Zhang, L.-P. Shi, Y.-F. Fu, Y.-C. Li, S. Ono, H. Fujiwara, et al.
(5R)-5-Hydroxytriptolide Attenuated Collagen-Induced Arthritis in DBA/1 Mice via Suppressing Interferon-{gamma} Production and Its Related Signaling
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. M. Bieber, L. Marcon, B. F. Hales, and B. Robaire
Effects of Chemotherapeutic Agents for Testicular Cancer on the Male Rat Reproductive System, Spermatozoa, and Fertility
J Androl, March 1, 2006; 27(2): 189 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Zhou, S.-X. Zheng, W. Tang, P.-L. He, X.-Y. Li, Y.-F. Yang, Y.-C. Li, J.-G. Geng, and J.-P. Zuo
Inhibition of Inducible Nitric-Oxide Synthase Expression by (5R)-5-Hydroxytriptolide in Interferon-{gamma}- and Bacterial Lipopolysaccharide-Stimulated Macrophages
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
P. Morales, M. Kong, E. Pizarro, C. Pasten, G. Morales, J. Borquez, and L. A. Loyola
Effect of Azorellanone, a Diterpene From Azorella yareta Hauman, on Human Sperm Physiology
J Androl, May 1, 2003; 24(3): 364 - 370.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Yang, J. Chen, Z. Guo, X.-M. Xu, L. Wang, X.-F. Pei, J. Yang, C. B. Underhill, and L. Zhang
Triptolide Inhibits the Growth and Metastasis of Solid Tumors
Mol. Cancer Ther., January 1, 2003; 2(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. A. Anderson and D. T. Baird
Male Contraception
Endocr. Rev., December 1, 2002; 23(6): 735 - 762.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by The American Society of Andrology.